12 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

InSee

FDA 510(k)
FDA Class 2 ·Anesthesiology

Oticon

FDA UDI
Sbo Hearing A/S·05714464055746·OTICON MORE 1 MINIRITE R C093 DEMO

LCP

FDA UDI
Synthes GmbH·10886982165992·3.5MM LCP T-PLATE 4H HEAD/ 5H SHAFT/67MM-RIGHT ...

Integra® Miltex®

FDA UDI
INTEGRA LIFESCIENCES PRODUCTION CORPORATION·10381780160069·Integra® Miltex® DEBAKEY Patent Ductus and Peri...

ADVANTAGE

FDA 510(k)
FDA Class 2 ·Anesthesiology

THINSET 1.8 ML RESERVOIR, MODEL 326A; THINSET 3.0 ML RESERVOIR, MODEL 332A

FDA 510(k)
FDA Class 2 ·General Hospital

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·August 29, 2025

ALARIS SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION SD·Product code FRN·October 27, 2023

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM 9.75 CM NON US

FDA Adverse Event
Injury ·COSTA RICA·Product code LTI·November 19, 2008

840 VENTILATOR

FDA Adverse Event
Malfunction ·COVIDIEN, FORMERLY NELLCOR·Product code CBK·August 17, 2011

LD304 MATERNITY BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code HDD·July 22, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014